Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome) Overview

Save information for later
Sign Up

Learn About Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)

What is the definition of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)?
Eosinophilic granulomatosis with polyangiitis (Churg Strauss syndrome) is a condition characterized by asthma, high levels of eosinophils (a type of white blood cell that helps fight infection), and inflammation of small to medium sized blood vessels (vasculitis). The inflamed vessels can affect various organ systems including the lungs, gastrointestinal tract, skin, heart and nervous system. The exact cause of Eosinophilic granulomatosis with polyangiitis is unknown, but it is thought to be an autoimmune disorder.
Who are the top Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome) Local Doctors?
Michael E. Wechsler
Elite in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Pulmonary Medicine | Intensive Care Medicine
Elite in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Pulmonary Medicine | Intensive Care Medicine

National Jewish Health

1400 Jackson St, 
Denver, CO 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Michael Wechsler is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Denver, Colorado. Dr. Wechsler is rated as an Elite provider by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). His top areas of expertise are Asthma, Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Hypereosinophilic Syndrome, and Eosinophilic Asthma. Dr. Wechsler is currently accepting new patients.

Elite in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Elite in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Oskar Alexander Str, 26, 
Bad Bramstedt, SH, DE 

Frank Moosig practices in Bad Bramstedt, Germany. Mr. Moosig is rated as an Elite expert by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). His top areas of expertise are Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Vasculitis, Granulomatosis with Polyangiitis, and Hypereosinophilic Syndrome.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Elite in Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
Paris, FR 

Loic Guillevin practices in Paris, France. Mr. Guillevin is rated as an Elite expert by MediFind in the treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome). His top areas of expertise are Necrotizing Vasculitis, Vasculitis, Polyarteritis Nodosa, Granulomatosis with Polyangiitis, and Kidney Transplant.

What are the latest Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome) Clinical Trials?
VCRC Genetic Repository One-Time DNA Protocol

Summary: The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researc...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Vasculitis Pregnancy Registry (V-PREG)

Summary: The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess 1. each woman's vasculitis severity and pregnancy-related experiences, and 2. pregnancy outcomes.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center